Use of a VEGF antagonist to treat angiogenic eye disorders | Patent Publication Number 20210308217

US 20210308217 A1

Patent NumberUS 11253572 B2

Application Number17352892

Filled DateJun 21, 2021

Priority DateJan 13, 2011

Publication DateOct 7, 2021

Original AssigneeRegeneron Pharmaceuticals

Current AssigneeRegeneron Pharmaceuticals

Inventor/ApplicantsGeorge YANCOPOULOS
George Yancopoulos

Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.

Check our Latest Report Purchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.